Pariet and arthralgia Patient Reports February 11, 2012
Pariet Side Effects Report #4595756-1
Pariet side effect was reported by a Health Professional from on Feb 11, 2005. Female patient, 51 years of age, weighting 145.5 lb, was diagnosed with dyspepsia and was treated with Pariet. After drug was administered, patient experienced the following side effects: arthralgia, constipation
, cough, difficulty in walking, erythema, insomnia, oedema peripheral. Pariet dosage: 10 MG 1 IN 1 D ORAL. During the same period patient was treated with TRESEQUENS. Patient recovered.Pariet Side Effects Report #5361305-3
Pariet side effect was reported by a Physician from JAPAN on June 01, 2007. Female patient, 59 years of age, weighting 125.7 lb, was diagnosed with duodenal ulcer haemorrhage and was treated with Pariet. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, c-reactive protein increased, hepatic function abnormal, muscular weakness, myalgia, myoglobin blood increased, pain in extremity. Pariet dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with FERROMIA, OMEPRAL. Patient was hospitalized. Patient recovered.
Pariet Side Effects Report #5374105-5
Pariet side effect was reported by a Physician from JAPAN on June 14, 2007. Female patient, 59 years of age, weighting 125.7 lb, was diagnosed with duodenal ulcer haemorrhage and was treated with Pariet. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, arthralgia, aspartate aminotransferase increased, blood creatine phosphokinase increased, c-reactive protein increased, haematoma, hepatic function abnormal, muscular weakness, myalgia. Pariet dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with FERROMIA, OMEPRAL. Patient was hospitalized. Patient recovered.
Pariet Side Effects Report #5657912-0
Pariet side effect was reported by a Physician from JAPAN on Feb 27, 2008. Male patient, 68 years of age, weighting 143.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with Pariet. After drug was administered, patient experienced the following side effects: arthralgia, blood calcium increased, bone marrow leukaemic cell infiltration, bone pain, cellulitis
, fasciitis, gait disturbance, haematocrit decreased, haematoma. Pariet dosage: 20 MG. During the same period patient was treated with MUCOSTA, GLEEVEC. Patient was hospitalized. Patient recovered.Pariet Side Effects Report #5729397-7
Pariet side effect was reported by a Physician from JAPAN on Apr 22, 2008. Male patient, 68 years of age, weighting 143.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with Pariet. After drug was administered, patient experienced the following side effects: arthralgia, blood calcium increased, bone marrow leukaemic cell infiltration, bone pain, cellulitis
, fasciitis, gait disturbance, haematocrit decreased, haematoma. Pariet dosage: 20 MG. During the same period patient was treated with MUCOSTA, GLEEVEC. Patient was hospitalized. Patient recovered.Pariet Side Effects Report #5729823-3
Pariet side effect was reported by a Physician from JAPAN on Apr 22, 2008. Male patient, 68 years of age, weighting 143.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with Pariet. After drug was administered, patient experienced the following side effects: arthralgia, blood calcium increased, bone marrow leukaemic cell infiltration, bone pain, cellulitis
, fasciitis, gait disturbance, haematocrit decreased, haematoma. Pariet dosage: 20 MG. During the same period patient was treated with MUCOSTA, GLEEVEC. Patient was hospitalized. Patient recovered.Pariet Side Effects Report #5730106-6
Pariet side effect was reported by a Physician from JAPAN on Apr 22, 2008. Male patient, 68 years of age, weighting 143.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with Pariet. After drug was administered, patient experienced the following side effects: arthralgia, blood calcium increased, bone marrow leukaemic cell infiltration, bone pain, cellulitis
, fasciitis, gait disturbance, haematocrit decreased, haematoma. Pariet dosage: 20 MG. During the same period patient was treated with MUCOSTA, GLEEVEC. Patient was hospitalized. Patient recovered.
Pariet and arthralgia 